Sasson, Alexa N.
Ananthakrishnan, Ashwin N. https://orcid.org/0000-0002-9436-1821
Article History
Received: 5 May 2021
Accepted: 29 May 2021
First Online: 12 June 2021
Declarations
:
: Sasson has no conflicts of interest to declare. Ananthakrishnan has served on the Scientific Advisory Boards of Gilead, Ikena Therapeutics, and Sun Pharma.
: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee. The Partners Healthcare Institutional Review Board approved this study.